Stock Comparison
BMY vs LLY
Bristol-Myers Squibb Company and Eli Lilly and Company side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$117.46B
$1.08T
P/E (TTM)
16.1
42.9
Forward P/E
8.8
31.1
Price/Sales
2.4
14.9
Price/Book
5.6
32.2
EV/EBITDA
9.9
28.8
Dividend Yield
4.51%
0.55%
Profitability
Net Margin
15.00%
35.00%
Operating Margin
33.00%
49.40%
Return on Equity
38.70%
107.50%
Return on Assets
10.70%
20.70%
Growth (YoY)
Revenue Growth
2.60%
55.50%
Earnings Growth
9.20%
169.90%
Price & Risk
Beta
0.2
0.5
52-Week High
$62.25
$1,215.76
52-Week Low
$41.46
$619.40
Analyst Target
$63.08
$1,222.62
Compare BMY and LLY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.